FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2178183718> ?p ?o ?g. }

• W2178183718 endingPage "3820" @default.
• W2178183718 startingPage "3796" @default.
• W2178183718 abstract "Pgp is functional on the plasma membrane and lysosomal membrane. Lysosomal-Pgp can pump substrates into the organelle, thereby trapping certain chemotherapeutics (e.g. doxorubicin; DOX). This mechanism serves as a “safe house” to protect cells against cytotoxic drugs. Interestingly, in contrast to DOX, lysosomal sequestration of the novel anti-tumor agent and P-glycoprotein (Pgp) substrate, di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), induces lysosomal membrane permeabilization. This mechanism of lysosomal-Pgp utilization enhances cytotoxicity to multidrug-resistant cells. Consequently, Dp44mT has greater anti-tumor activity in drug-resistant relative to non-Pgp-expressing tumors. Interestingly, stressors in the tumor microenvironment trigger endocytosis for cell signaling to assist cell survival. Hence, this investigation examined how glucose variation-induced stress regulated early endosome and lysosome formation via endocytosis of the plasma membrane. Furthermore, the impact of glucose variation-induced stress on resistance to DOX was compared with Dp44mT and its structurally related analogue, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC). These studies showed that glucose variation-induced stress-stimulated formation of early endosomes and lysosomes. In fact, through the process of fluid-phase endocytosis, Pgp was redistributed from the plasma membrane to the lysosomal membrane via early endosome formation. This lysosomal-Pgp actively transported the Pgp substrate, DOX, into the lysosome where it became trapped as a result of protonation at pH 5. Due to increased lysosomal DOX trapping, Pgp-expressing cells became more resistant to DOX. In contrast, cytotoxicity of Dp44mT and DpC was potentiated due to more lysosomes containing functional Pgp under glucose-induced stress. These thiosemicarbazones increased lysosomal membrane permeabilization and cell death. This mechanism has critical implications for drug-targeting in multidrug-resistant tumors where a stressful micro-environment exists. Pgp is functional on the plasma membrane and lysosomal membrane. Lysosomal-Pgp can pump substrates into the organelle, thereby trapping certain chemotherapeutics (e.g. doxorubicin; DOX). This mechanism serves as a “safe house” to protect cells against cytotoxic drugs. Interestingly, in contrast to DOX, lysosomal sequestration of the novel anti-tumor agent and P-glycoprotein (Pgp) substrate, di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), induces lysosomal membrane permeabilization. This mechanism of lysosomal-Pgp utilization enhances cytotoxicity to multidrug-resistant cells. Consequently, Dp44mT has greater anti-tumor activity in drug-resistant relative to non-Pgp-expressing tumors. Interestingly, stressors in the tumor microenvironment trigger endocytosis for cell signaling to assist cell survival. Hence, this investigation examined how glucose variation-induced stress regulated early endosome and lysosome formation via endocytosis of the plasma membrane. Furthermore, the impact of glucose variation-induced stress on resistance to DOX was compared with Dp44mT and its structurally related analogue, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC). These studies showed that glucose variation-induced stress-stimulated formation of early endosomes and lysosomes. In fact, through the process of fluid-phase endocytosis, Pgp was redistributed from the plasma membrane to the lysosomal membrane via early endosome formation. This lysosomal-Pgp actively transported the Pgp substrate, DOX, into the lysosome where it became trapped as a result of protonation at pH 5. Due to increased lysosomal DOX trapping, Pgp-expressing cells became more resistant to DOX. In contrast, cytotoxicity of Dp44mT and DpC was potentiated due to more lysosomes containing functional Pgp under glucose-induced stress. These thiosemicarbazones increased lysosomal membrane permeabilization and cell death. This mechanism has critical implications for drug-targeting in multidrug-resistant tumors where a stressful micro-environment exists." @default.
• W2178183718 created "2016-06-24" @default.
• W2178183718 creator A5010643006 @default.
• W2178183718 creator A5017608428 @default.
• W2178183718 creator A5061763563 @default.
• W2178183718 creator A5083775667 @default.
• W2178183718 date "2016-02-01" @default.
• W2178183718 modified "2023-10-03" @default.
• W2178183718 title "Glucose Modulation Induces Lysosome Formation and Increases Lysosomotropic Drug Sequestration via the P-Glycoprotein Drug Transporter" @default.
• W2178183718 cites W1485015899 @default.
• W2178183718 cites W1502461041 @default.
• W2178183718 cites W1550693195 @default.
• W2178183718 cites W1555340212 @default.
• W2178183718 cites W1578072993 @default.
• W2178183718 cites W1647656396 @default.
• W2178183718 cites W1964615735 @default.
• W2178183718 cites W1964870672 @default.
• W2178183718 cites W1966255834 @default.
• W2178183718 cites W1966311581 @default.
• W2178183718 cites W1970631293 @default.
• W2178183718 cites W1970909818 @default.
• W2178183718 cites W1973097909 @default.
• W2178183718 cites W1976251743 @default.
• W2178183718 cites W1976463957 @default.
• W2178183718 cites W1977373583 @default.
• W2178183718 cites W1980042430 @default.
• W2178183718 cites W1981872407 @default.
• W2178183718 cites W1983946174 @default.
• W2178183718 cites W2000590497 @default.
• W2178183718 cites W2002526053 @default.
• W2178183718 cites W2013658500 @default.
• W2178183718 cites W2016168978 @default.
• W2178183718 cites W2018367629 @default.
• W2178183718 cites W2020444094 @default.
• W2178183718 cites W2023317996 @default.
• W2178183718 cites W2032717943 @default.
• W2178183718 cites W2033346155 @default.
• W2178183718 cites W2035252444 @default.
• W2178183718 cites W2038049117 @default.
• W2178183718 cites W2038402760 @default.
• W2178183718 cites W2040905261 @default.
• W2178183718 cites W2041687573 @default.
• W2178183718 cites W2042218168 @default.
• W2178183718 cites W2042619042 @default.
• W2178183718 cites W2045769183 @default.
• W2178183718 cites W2046133662 @default.
• W2178183718 cites W2048764176 @default.
• W2178183718 cites W2049442302 @default.
• W2178183718 cites W2050517391 @default.
• W2178183718 cites W2073823253 @default.
• W2178183718 cites W2075267380 @default.
• W2178183718 cites W2077527631 @default.
• W2178183718 cites W2078846752 @default.
• W2178183718 cites W2079687293 @default.
• W2178183718 cites W2080878773 @default.
• W2178183718 cites W2085649019 @default.
• W2178183718 cites W2086943351 @default.
• W2178183718 cites W2087785496 @default.
• W2178183718 cites W2091849811 @default.
• W2178183718 cites W2094148780 @default.
• W2178183718 cites W2096892716 @default.
• W2178183718 cites W2097494814 @default.
• W2178183718 cites W2098930497 @default.
• W2178183718 cites W2099616702 @default.
• W2178183718 cites W2107373516 @default.
• W2178183718 cites W2108471384 @default.
• W2178183718 cites W2110068304 @default.
• W2178183718 cites W2119748249 @default.
• W2178183718 cites W2122637273 @default.
• W2178183718 cites W2127242883 @default.
• W2178183718 cites W2138364046 @default.
• W2178183718 cites W2142142736 @default.
• W2178183718 cites W2147233164 @default.
• W2178183718 cites W2150737519 @default.
• W2178183718 cites W2150926026 @default.
• W2178183718 cites W2153654059 @default.
• W2178183718 cites W2156088967 @default.
• W2178183718 cites W2159401034 @default.
• W2178183718 cites W2160650811 @default.
• W2178183718 cites W2161396884 @default.
• W2178183718 cites W2169647073 @default.
• W2178183718 cites W2170070957 @default.
• W2178183718 cites W2312836697 @default.
• W2178183718 cites W2409523681 @default.
• W2178183718 cites W4231136244 @default.
• W2178183718 doi "https://doi.org/10.1074/jbc.m115.682450" @default.
• W2178183718 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4759162" @default.
• W2178183718 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26601947" @default.
• W2178183718 hasPublicationYear "2016" @default.
• W2178183718 type Work @default.
• W2178183718 sameAs 2178183718 @default.
• W2178183718 citedByCount "51" @default.
• W2178183718 countsByYear W21781837182016 @default.
• W2178183718 countsByYear W21781837182017 @default.
• W2178183718 countsByYear W21781837182018 @default.
• W2178183718 countsByYear W21781837182019 @default.
• W2178183718 countsByYear W21781837182020 @default.
• W2178183718 countsByYear W21781837182021 @default.

• next